Article
A possible favorable effect of colchicine in IgA nephropathy in a carrier of a MEFV mutation.
Clinical nephrology - 1 Sept 2004
Koukoui L, Blau A, Kopolovic J, Pras M, Livneh A
Abstract excerpt
IgA nephropathy is the most common primary glomerulopathy. Currently, no satisfactory treatment is available and as a result, a significant proportion of affected patients progress to end-stage renal disease. We present a patient with IgA nephropathy in whom continuous colchicine treatment induced remission, which has lasted for 22 years. The patient was a carrier of a mutation in the FMF gene (MEFV). This case...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.